Ipca Laboratories (IPCALAB.BO) Earnings Analysis
Ipca Laboratories (IPCALAB.BO) next reports earnings on 2026-08-17, consensus EPS 12.16 INR. Last quarter (2026-05-29) it beat with EPS 11.8 INR vs 10.07 INR est (+17.2%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 39.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IPCALAB.BO next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | 12.16 INR |
| Revenue estimate | 25.85B |
IPCALAB.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-29 | 11.8 INR | 10.07 INR | +17.2% | Beat |
| 2026-02-13 | 12.2 INR | 11.66 INR | +4.6% | Beat |
| 2025-08-11 | 9.19 INR | 11.5 INR | -20.1% | Miss |
| 2025-05-29 | 2.67 INR | 8.77 INR | -69.6% | Miss |
| 2024-11-14 | 9.05 INR | 8.5 INR | +6.5% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
IPCALAB.BO valuation and analyst view
| Trailing P/E | 39.31 |
|---|---|
| Trailing EPS | 44.985 INR |
| Price / book | 5.56 |
| Dividend yield | 0.23% |
| Market cap | 453.58B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ipca Laboratories (IPCALAB.BO)'s next earnings date?
Ipca Laboratories is next scheduled to report on 2026-08-17, with a consensus EPS estimate of 12.16 INR and revenue estimate of 25.85B.
Did IPCALAB.BO beat earnings last quarter?
In its 2026-05-29 report, IPCALAB.BO posted EPS of 11.8 INR versus a 10.07 INR estimate — a beat of 17.2%.
What is IPCALAB.BO's earnings track record?
Over the last 5 reported quarters with consensus data, IPCALAB.BO beat estimates 3 times (60%).
What is IPCALAB.BO's current P/E ratio and EPS?
IPCALAB.BO trades at a trailing P/E of 39.31 on trailing EPS of 44.98547098434362 INR.
What do analysts rate IPCALAB.BO?
IPCALAB.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.